Three articles are highlighted in the June issue. The first featured article is “Increasing Physical Activity and Exercise in Lung Cancer: Reviewing Safety, Benefits, and Application” by Bade et al. This article reviews the available data on the role of exercise and physical activity in the management of lung cancer – an important topic which in my view is not studied as much as it should be.
Kwon and colleagues demonstrate in an elegant study that FDG uptake on Positron Emission Tomography is predictive of survival and time to recurrence in early stage Non-Small Cell Lung Cancer, in the manuscript, “FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small Cell Lung Cancer”.
In the third highlighted manuscript, “Patients selected for definitive concurrent chemo-radiation at high-volume facilities achieve improved survival in stage III non-small cell lung cancer”, Park et al analyzed over 10,000 cases from the US national cancer data base and demonstrated that the survival of stage III patients treated with chemo-radiation in high volume facilities was superior to those treated in other institutions. Interestingly, these results were independent of academic affiliation.
Alex A. Adjei, MD, PhD, Editor-in-Chief